Genomics, the whole-genome study of structure, function, and evolution

Genetics studies individual genes, their inheritance patterns, mutations, and functions. Genomics takes a holistic approach, studying all genes and non-coding sequences in the genome simultaneously. For example, genetics might investigate a single BRCA1 mutation in breast cancer, while genomics would sequence the entire tumor genome to identify all mutations, copy number changes, and structural variants contributing to cancer development and treatment response.

Medical genomics applications include: (1) diagnosing rare genetic diseases through WES/WGS, (2) oncology — identifying driver mutations for targeted therapy selection, (3) pharmacogenomics — predicting drug response based on genetic variants, (4) prenatal screening through non-invasive prenatal testing (NIPT), (5) carrier screening for recessive disorders, (6) infectious disease genomics — tracking pathogen evolution and drug resistance, and (7) precision public health — population-level genomic surveillance.

Genomic information is essential for primer design because primers must be specific to their target within the context of the entire genome. A human genomic template is 3.2 billion base pairs — primers must uniquely amplify the intended region without off-target binding. VigyanLLM's primer design tool uses BLAST alignment against complete reference genomes (NCBI RefSeq) to verify specificity, checks for SNP overlap using dbSNP and gnomAD databases, and masks repetitive elements identified through genomic annotation.

Genetics studies individual genes and their inheritance patterns, focusing on specific traits or diseases caused by single gene variants. Genomics analyzes the entire genome — all genes, regulatory elements, and non-coding DNA — to understand their collective structure, function, and interactions. Genomics uses high-throughput technologies like next-generation sequencing.

NGS is a high-throughput DNA sequencing technology that parallelly sequences millions of DNA fragments simultaneously. Unlike Sanger sequencing which sequences one fragment at a time, NGS enables whole-genome sequencing, targeted sequencing, RNA-seq, and epigenomic profiling in a single run. Illumina sequencing-by-synthesis is the most widely used NGS technology.

Genome assembly is the process of reconstructing complete chromosome sequences from short DNA sequencing reads. It involves overlapping reads to form longer contiguous sequences (contigs), ordering contigs into scaffolds, and anchoring scaffolds to chromosomes. Reference-quality assemblies require high coverage (30-60x) and a combination of short-read and long-read sequencing technologies.

The human genome reference is a digital representation of the human genome used as a standard for comparison in genomic studies. Current version GRCh38 (hg38) covers approximately 3.1 billion base pairs. It is a composite derived from multiple individuals and continues to be refined with gap-free telomere-to-telomere assemblies from the T2T Consortium.

Genomics enables precision medicine by identifying genetic variants that influence drug response (pharmacogenomics), predicting disease risk from polygenic risk scores, guiding cancer treatment based on tumor mutational profiles, diagnosing rare genetic diseases through whole-exome or whole-genome sequencing, and monitoring treatment response through liquid biopsies.

GWAS scans the genomes of thousands of individuals to identify single nucleotide polymorphisms (SNPs) associated with a particular trait or disease. It compares SNP frequencies between cases and controls, identifying statistically significant associations. GWAS has discovered thousands of genetic variants linked to complex diseases but typically explains only a fraction of heritability.

Single nucleotide polymorphisms (SNPs) change one DNA base and are the most common type of genetic variation. Structural variants (SVs) are larger changes affecting 50+ base pairs, including deletions, duplications, inversions, insertions, and translocations. SVs affect more total base pairs of the genome than SNPs but are harder to detect with standard short-read sequencing.